Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 06, 2024
The Board of Directors of Entero Healthcare Solutions Limited ('Company') has approved, inter-alia, to execute the definitive agreements to acquire 80% paid-up equity share capital of Avenir Lifecare Pharma Private Limited ('ALPPL') at their meeting held today i.e. 6th May 2024. Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd Entero Healthcare Solutions Ltd - 544122 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyEntero Healthcare Solutions Ltd 2CIN NO.U74999HR2018PLC072204 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY INDBBB 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Jayant Prakash Designation: General Counsel Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: venkataramana Ram Chebolu Designation: Chief Financial Officer EmailId: [email protected] Date: 25/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Entero Healthcare Solutions Ltd - 544122 - Compliance Certificate In Terms Of Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Submission of Compliance certificate in terms of Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Jefferies Initiates 'Buy' On Entero Healthcare, Stock Hits 20% Upper Limit
Jefferies estimates Entero to log a 44% revenue CAGR and an eight-times increase in adjusted profit after tax over FY2426. Entero Healthcare Solutions Ltd - 544122 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate under Regulation 74 (5) of SEBI Depository Participant Regulation, 2018 for the quarter ended March 31, 2024. Entero Healthcare Solutions Ltd - 544122 - Disclosure In Compliance With SEBI Circular No. SEBI/HO/CFD/Cmdl/CIR/2019/140 Dated November 21, 2019, Of Default On Payment Of Interest/ Repayment Of Principal Amount On Loans From Bank( S)/ Financial Institutions And Unlisted Debt Securities.
Disclosure in compliance with SEBI Circular No, SEBI/HO/CFD/CMDI/CIR/2019/140 dated November 21, 2019 of default on payment of Interest/ repayment of principal amount on loans from Bank(s)/financial institution and unlisted debt securities.